Completed PHASE1/PHASE2 INTERVENTIONAL NCT00827398

Treatment of Steroid Resistant GVHD by Infusion MSC (MSCforGVHD)

Treatment of Steroid Resistant Grade II to IV GVHD by Infusion MSCof Mesenchymal Stem Cells Expanded With Human Plasma and Platelet Lysate a Phase I/II Study

Sponsor: N.M. Wulffraat

Conditions Graft-versus-host-disease

Interventions MSC (hPPL)

Updated 5 times since 2017 Last updated: Nov 5, 2014 Started: Jan 31, 2009 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Graft-versus-host-disease, this trial is completed. The trial is conducted by N.M. Wulffraat and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

N.M. Wulffraat

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands